Additionally, DPP-4 inhibitors have been shown to improve abnormal liver transaminases levels such as aspartate aminotransferase and alanine transaminase, in patients with T2DM with liver dysfunction
Pending legislation Medications like Wegovy and Zepbound arent typically covered by Medicaid, but coverage may change in the future
Repeated missed doses can cause blood sugar levels to fluctuate, increase hunger, and stall your weight loss results
WHAT COMES NEXT The new findings do not, by themselves, justify prescribing GLP-1 drugs to prevent or treat substance use disorders, Al-Aly said
Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of kidney outcomes: emulation of a target trial using health care databases